PharmaCann

Illinois' cannabis landscape is experiencing a dynamic transformation, showcasing both significant milestones and persistent challenges in its journey toward inclusivity and expansion. Gov. Jay Robert "J.B." Pritzker (D), a driving force behind this evolution, is set to take center...

XS Financial Inc. (OTCQB: XSHLF) (CSE:XSF)a specialty finance company providing CAPEX and equipment financing solutions to cannabis companies in the United States, has entered into a new lease with PharmaCann Inc, for $7.6 million. PharmaCann continues to deploy resources from its pre-existing $30...

A well-established marijuana dispensary in Rhode Island has filed a lawsuit contesting a provision of the state's cannabis legalization law that mandates retailers to establish labor agreements with their employees as a prerequisite for selling marijuana, reported The Boston Globe. Greenleaf...

Teamsters Local 777 members at Verilife dispensaries in Illinois, owned by PharmaCann, ratified their first collective bargaining agreements in early May, which provide workers a 20% wage increase, additional full-time positions, guaranteed gratuities and employer-funded retirement...

XS Financial Inc. (CSE: XSF) (OTCQB: XSHLF) released earnings for the fourth quarter and fiscal year ended December 31, 2022. The specialty finance company, which is dedicated to U.S.-based cannabis companies, had "a transformational year," according to CEO David Kivitz. "We had...

The Coalition for Access to Regulated and Safe Cannabis (CARSC) recently sued New York's Office of Cannabis Management (OCM) for allegedly violating the Marijuana Regulation and Tax Act (MRTA). The Claim Continues… In response to recent events, the New York MSO Coalition released a...

On Monday, Crain's Chicago released a list of Chicago's largest marijuana companies. These leading cannabis industry players in the Midwest city inlcude: publicly traded Cresco Labs Inc (OTCQX: CRLBF) (CSE: CL), Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF), and Green Thumb...

In a first for Chicago sports, a cannabis company will be a featured sponsor at all Chicago Wolves home games. The Illinois cannabis brand, Verilife, has entered into a sponsorship with the 2022 American Hockey League champions.  The first-of-its-kind agreement between a...

Sporos Capital Partners, a cannabis private equity firm, has closed on its equity investment in Story Companies LLC, a privately-held multi-state operator. Proceeds of the investment, from a Sporos affiliated vehicle, will be used to support the growth and expansion of Story’s vertically-...

Jon Levine, president of Marimed Inc., Brett Novey, CEO of Pharmacann and Andrew Thut, CIO of 4Front Ventures, operators in the Midwest and across the country, joined Barbara Webb, partner of MGO, and Steve Miles, CEO of Sharp Capital Advisors in a panel at Benzinga’s Cannabis Capital...

Innovative Industrial Properties, Inc. (NYSE: IIPR) revenues in Q2 2022 were approximately $70.5 million, compared to approximately $48.9 million in Q2 2021, an increase of 44%. Q2 2022 Highlights Financial Results and Capital Activity Recorded net income attributable to common stockholders of...

In select studies, celebrity endorsements have produced an average 4% sales increase. At this time, it appears that isn't the case in the US cannabis market. To date, most celebrity cannabis brands, whether endorsed or owned, leave some questioning their market impact. The unease appears...

Cannabis companies PharmaCann Inc. and LivWell Enlightened Health completed their previously disclosed definitive merger agreement for PharmaCann to acquire LivWell Holdings, Inc. The combination of PharmaCann and LivWell is a natural fit given our shared commitment to improving people’s...

One of the largest private cannabis companies in the world could soon go public on the OTC Markets with a valuation of more than $1 billion. According to a report from Reuters, PharmaCann, a Chicago-based, vertically integrated company with operations in six states including the highly-coveted...

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) is poised to acquire a stake in PharmaCann for approximately $110.4 million. Transaction Details: Under the terms of the agreement, a wholly-owned subsidiary of the Toronto-headquartered company has bought an option to obtain a roughly 10.5% ownership...